Skip to main content
OpenTrials

Clinical trial condition

Primary Central Nervous System Non-Hodgkin Lymphoma

Explore clinical trials studying Primary Central Nervous System Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

12 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Primary Central Nervous System Non-Hodgkin Lymphoma trial results

Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 25 locations
View Trial Details
Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details

Related conditions